Please login to the form below
medicines
This page shows the latest medicines news and features for those working in and with pharma, biotech and healthcare.
Gilead’s Jyseleca is given a NICE recommendation for rheumatoid arthritis
Jyseleca (filgotinib) is an oral JAK inhibitor that can be administered as a monotherapy or used alongside another another common RA medicine called methotrexate. ... While no single medicine works for everyone, the addition of Jyseleca is an important
Latest news
-
Lateral flow tests detect ‘most infectious’ COVID-19 cases, Oxford researchers find
prevent further onward spread,” said Tim Peto, professor of medicine at the University of Oxford and senior author on the study.
-
Relics from the past
Terms that were once perfectly descriptive now only serve to tell us how the world has changed
-
Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
In December 2020, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) issued guidance warning people with a history of allergic reactions not to get the Pfizer/BioNTech COVID-19
-
Lilly partners with Merus on development of bispecific antibodies for cancer
We look forward to working closely with Merus to develop new potential medicines for patients with cancer,” he added.
-
Cambridge University develops DNA test for secondary infections in COVID-19 patients
developed for just such a situation,” said co-author Andrew Conway Morris, from Cambridge’s Department of Medicine and an intensive care consultant.
More from news
Approximately 177 fully matching, plus 4,124 partially matching documents found.
Latest Intelligence
-
The pandemic preparedness paradox
And we know how to translate academic inventions into medicines that can help patients, but today that’s not happening, because there is no market for sporadic infectious diseases. ... An operating, drug-developing PPP focused solely on translating the
-
Sourcing R&D innovation: why pharma companies need to evolve their business models
In decades past, pharmaceutical and then biotechnology companies worked to develop therapies to address unmet medical needs in general medicine that were often considered ‘low hanging fruit’. ... the pipeline, the use of technology in medicine is
-
The search for effective drug treatments for COVID-19
and efficacy of medicines when they are developed, a process that takes several years. ... This data was peer-reviewed and published in the New England Journal of Medicine.
-
Putting theory into practice
He has been hugely, if invisibly, influential in how we launch new medicines and medical technology.
-
Successful product commercialisation: what can we learn from the rare disease setting?
In the field of rare diseases, it’s common to come across statements that emphasise how launching a rare disease medicine demands a different launch model from that of traditional drugs. ... For novel therapies (including medicines aimed at rare
More from intelligence
Approximately 22 fully matching, plus 582 partially matching documents found.
Latest appointments
-
Merck’s R&D chief Roger Perlmutter heads for the exit as Dean Li takes the helm
Over the course of his most recent stint at Merck, the company has achieved over 100 regulatory approvals for its medicines and vaccines globally. ... Succeeding Perlmutter as the head of Merck R&D is Dean Li, currently senior vice president of discovery
-
New hires at EMA, Gilead and BeiGene
European Medicines Agency (EMA). The European Medicines Agency (EMA) management board has nominated Emer Cooke (pictured above) as its new executive director. ... Raitt professor of medicine and clinical chief in the division of immunology and
-
NICE looks internally for new chief executive
Originally training in medicine, Leng went on to work on clinical trials and epidemiological research as well as a consultant in public health medicine.
-
Genmab hires first chief operating officer
Most recently, he led Bristol-Myers Squibb’s US innovative medicines unit, where he managed a team of over 1000 people focused on immunology and cardiovascular diseases.
-
Four Health announces a pair of internal promotions
role of the NHS in public health and prevention medicine.
More from appointments
Approximately 10 fully matching, plus 354 partially matching documents found.
Latest from PMHub
-
Mistrust in medical research: a patient perspective
She concludes that Thalidomide completely changed the way medicines are tested and approved. ... The Royal Society of Medicine has been running a series of COVID-19 webinars.
-
My Journey Into MedComms #LucidLife
I graduated university with a BSc in pharmacology in 2017. Career-wise, I wanted a role that would combine my fascination for science and medicine with the opportunity to work in
-
2020 - a year to remember or forget?
All while we were relocating our offices to our homes. But as we all know, the world of healthcare doesn’t ever stop – patients still need access to medicines and support ... HCPs had to adjust how they delivered care (often though telemedicine) and
-
emotive supports Rare Disease Day 2019
On 20th February, we attended ‘The Unusual Suspects: Rare Diseases in Everyday Medical Care” at the Royal Society of Medicine, hosted by Medics 4 Rare Diseases (M4RD). . ... work we do in such an innovative area of medicine. .
-
Mednet Group’s growth spurt
ve settled in quickly with the team being so friendly and I’m looking forward to getting involved in a range of projects in the field of healthcare and medicine.”.
More from PMHub
Approximately 36 fully matching, plus 310 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Account Director
-
Competitive
-
Medical Editor
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- Nucleus Global announces a trio of promotions
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
